AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
Clinical trial NCT04885998 · COMPLETED
Trial details
- NCT number
- NCT04885998
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2023-07-12
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.